SCLN
Sciclone Pharmaceuticals Inc
SCLN
SCLN
Delisted
SCLN was delisted on the 13th of October, 2017.
142 hedge funds and large institutions have $422M invested in Sciclone Pharmaceuticals Inc in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
82% less call options, than puts
Call options by funds: $214K | Put options by funds: $1.17M
Holders
142
Holding in Top 10
1
Calls
$214K
Puts
$1.17M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$7.68M | |
| 3 | +$5.02M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.4M |
| 5 |
GH
GAM Holding
Zurich,
Switzerland
|
+$4.26M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$15.9M | |
| 3 | -$3.98M | |
| 4 |
BlackRock
New York
|
-$2.7M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.34M |